Epoprostenol/sildenafilLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33192-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：307 / 307

相关论文

共 50 条

[21] Epoprostenol/levosimendanLack of efficacy: case report
Reactions Weekly, 2020, 1824 (1) : 129 - 129
[22] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 226 - 226
[23] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 240 - 240
[24] Epoprostenol/isavuconazole/voriconazoleLack of efficacy: case report
Reactions Weekly, 2022, 1922 (1) : 258 - 258
[25] Dobutamine/dopamine/sildenafilLack of efficacy and various toxicities: case report
Reactions Weekly, 2024, 2029 (1) : 225 - 225
[26] Epoprostenol/propofolHypertriglyceridaemia and lack of efficacy: case report
Reactions Weekly, 2021, 1839 (1) : 131 - 131
[27] Epoprostenol/Milrinone/NorepinephrineLack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 265 - 265
[28] Epoprostenol/sildenafil/treprostinilLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 183 - 183
[29] SildenafilLack of efficacy following off label use: case report
Reactions Weekly, 2024, 2035 (1) : 456 - 456
[30] SildenafilLack of efficacy and maternal exposure during pregnancy: case report
Reactions Weekly, 2025, 2054 (1) : 407 - 407

← 1 2 3 4 5 →